title: Commentary: risks and benefits, testing and screening, cancer, genes and dollars.
abstract: Author argues that the current, restrictive policy for genetic screening for cancer risk is appropriate but that diagnostic testing decisions should not be so narrowly regulated.
authors.affiliation: Case Western Reserve University School of Medicine, Cleveland, USA.
authors.forename: E
authors.initials: E
authors.lastname: Kodish
mesh_terms: D026683:Advisory Committees; D003362:Cost-Benefit Analysis; D003657:Decision Making; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D030661:Genetic Privacy; D033142:Genetic Services; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D009369:Neoplasms / Q000191:economics / Q000517:prevention & control*; D018570:Risk Assessment; D014481:United States